Rep. Jake Auchincloss (D-Mass.) has some advice for fellow lawmakers: unapologetically support the biotech industry.

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, presented its first in vivo ...

Krystal Biotech Inc. KRYS on Thursday released a clinical update for its intratumoral immunotherapy, KB113. The treatment ...

While industry leaders are unsure whether the U.S. or China will prevail, they are largely united in the belief that Europe ...

Frazier Life Sciences also hit the Nasdaq on Friday with its second biotech-focused special purpose acquisition company (SPAC ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Iambic Therapeutics, an AI-enabled biotech company, will apply the IPO proceeds toward clinical development of its pipeline ...

Unsecured, non-interest-bearing loan provides additional working capital supportWINNIPEG, Manitoba, Oct. 16, 2026 (GLOBE NEWSWIRE) -- (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”), a ...

Biotech stocks saw sharp moves in Friday's premarket trading, led by gains in Alaunos Therapeutics following a major ...

Loyal’s dog longevity pill, $50,000 Viagen clones and Alcor’s frozen pets show biotech’s push to keep animals around longer.

The list of departing ASX biotech CEOs continues to swell, with Medical Developments chief Brent MacGregor signing off today.